Earnings
ALGN
187.60
+6.82%
11.98
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
4.03B
4.03B
--
1.32B
2.71B
2.17B
1.76B
369.91M
--
--
39.56M
--
545.75M
16.05M
--
23.49M
585.29M
174.94M
410.35M
--
--
--
410.35M
--
410.35M
--
410.35M
410.35M
--
410.35M
72.59M
5.65
5.65
--
8.13
FY 2024
4.00B
4.00B
--
1.20B
2.80B
2.19B
1.76B
364.20M
--
--
64.14M
--
607.63M
20.22M
--
-18.89M
608.96M
187.60M
421.36M
--
--
--
421.36M
--
421.36M
--
421.36M
421.36M
--
421.36M
74.99M
5.62
5.62
--
6.21
FY 2023
3.86B
3.86B
--
1.16B
2.71B
2.06B
1.70B
346.83M
--
--
13.32M
--
643.34M
17.26M
--
-19.39M
641.20M
196.15M
445.05M
--
--
--
445.05M
--
445.05M
--
445.05M
445.05M
--
445.05M
76.57M
5.81
5.81
--
5.93
FY 2022
3.73B
3.73B
--
1.10B
2.63B
1.99B
1.67B
305.26M
--
--
11.45M
--
642.60M
5.37M
--
-48.91M
599.06M
237.48M
361.57M
--
--
--
361.57M
--
361.57M
--
361.57M
361.57M
--
361.57M
78.42M
4.61
4.61
--
4.70
FY 2021
3.95B
3.95B
--
1.02B
2.94B
1.92B
1.71B
250.31M
--
--
-43.40M
--
1.02B
3.10M
--
-10.48M
1.01B
240.40M
772.02M
--
0.00
--
772.02M
--
772.02M
--
772.02M
772.02M
--
772.02M
79.67M
9.69
9.69
--
9.27

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.